Search research articles
Contact Us
Filters
Showing results (31-40 of 58) with videos related to
Page
of 6
Sort By:
Science Translational Medicine
|
December 8, 2022
A randomized controlled trial showing safety and efficacy of a whole sporozoite vaccine against endemic malaria
Sodiomon B Sirima, Alphonse Ouédraogo, Alfred B Tiono, et al.
The American Journal of Tropical Medicine and Hygiene
|
July 30, 2014
Controlled human malaria infection of Tanzanians by intradermal injection of aseptic, purified, cryopreserved Plasmodium falciparum sporozoites
Seif Shekalaghe, Mastidia Rutaihwa, Peter F Billingsley, et al.
Malaria Journal
|
August 7, 2015
Controlled human malaria infection by intramuscular and direct venous inoculation of cryopreserved Plasmodium falciparum sporozoites in malaria-naïve volunteers: effect of injection volume and dose on infectivity rates
Gloria P Gómez-Pérez, Almudena Legarda, Jose Muñoz, et al.
Nature Medicine
|
September 14, 2021
Safety, immunogenicity and efficacy of PfSPZ Vaccine against malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trial
Martina Oneko, Laura C Steinhardt, Reuben Yego, et al.
The Lancet. Infectious Diseases
|
November 21, 2021
Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial
Mahamadou S Sissoko, Sara A Healy, Abdoulaye Katile, et al.
Nature
|
February 16, 2017
Sterile protection against human malaria by chemoattenuated PfSPZ vaccine
Benjamin Mordmüller, Güzin Surat, Heimo Lagler, et al.
The Journal of Clinical Investigation
|
January 9, 2024
Safety and protective efficacy of PfSPZ Vaccine administered to HIV-negative and -positive Tanzanian adults
Said Jongo, L W Preston Church, Florence Milando, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 30, 2019
Increase of Dose Associated With Decrease in Protection Against Controlled Human Malaria Infection by PfSPZ Vaccine in Tanzanian Adults
Said A Jongo, L W Preston Church, Ali T Mtoro, et al.
The American Journal of Tropical Medicine and Hygiene
|
November 17, 2017
Advancing Global Health through Development and Clinical Trials Partnerships: A Randomized, Placebo-Controlled, Double-Blind Assessment of Safety, Tolerability, and Immunogenicity of PfSPZ Vaccine for Malaria in Healthy Equatoguinean Men
Ally Olotu, Vicente Urbano, Ali Hamad, et al.
Frontiers in Microbiology
|
January 8, 2015
Evaluating controlled human malaria infection in Kenyan adults with varying degrees of prior exposure to Plasmodium falciparum using sporozoites administered by intramuscular injection
Susanne H Hodgson, Elizabeth Juma, Amina Salim, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 58) with videos related to
Sort By:
Page
of 6
Science Translational Medicine
|
December 8, 2022
A randomized controlled trial showing safety and efficacy of a whole sporozoite vaccine against endemic malaria
Sodiomon B Sirima, Alphonse Ouédraogo, Alfred B Tiono, et al.
The American Journal of Tropical Medicine and Hygiene
|
July 30, 2014
Controlled human malaria infection of Tanzanians by intradermal injection of aseptic, purified, cryopreserved Plasmodium falciparum sporozoites
Seif Shekalaghe, Mastidia Rutaihwa, Peter F Billingsley, et al.
Malaria Journal
|
August 7, 2015
Controlled human malaria infection by intramuscular and direct venous inoculation of cryopreserved Plasmodium falciparum sporozoites in malaria-naïve volunteers: effect of injection volume and dose on infectivity rates
Gloria P Gómez-Pérez, Almudena Legarda, Jose Muñoz, et al.
Nature Medicine
|
September 14, 2021
Safety, immunogenicity and efficacy of PfSPZ Vaccine against malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trial
Martina Oneko, Laura C Steinhardt, Reuben Yego, et al.
The Lancet. Infectious Diseases
|
November 21, 2021
Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial
Mahamadou S Sissoko, Sara A Healy, Abdoulaye Katile, et al.
Nature
|
February 16, 2017
Sterile protection against human malaria by chemoattenuated PfSPZ vaccine
Benjamin Mordmüller, Güzin Surat, Heimo Lagler, et al.
The Journal of Clinical Investigation
|
January 9, 2024
Safety and protective efficacy of PfSPZ Vaccine administered to HIV-negative and -positive Tanzanian adults
Said Jongo, L W Preston Church, Florence Milando, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 30, 2019
Increase of Dose Associated With Decrease in Protection Against Controlled Human Malaria Infection by PfSPZ Vaccine in Tanzanian Adults
Said A Jongo, L W Preston Church, Ali T Mtoro, et al.
The American Journal of Tropical Medicine and Hygiene
|
November 17, 2017
Advancing Global Health through Development and Clinical Trials Partnerships: A Randomized, Placebo-Controlled, Double-Blind Assessment of Safety, Tolerability, and Immunogenicity of PfSPZ Vaccine for Malaria in Healthy Equatoguinean Men
Ally Olotu, Vicente Urbano, Ali Hamad, et al.
Frontiers in Microbiology
|
January 8, 2015
Evaluating controlled human malaria infection in Kenyan adults with varying degrees of prior exposure to Plasmodium falciparum using sporozoites administered by intramuscular injection
Susanne H Hodgson, Elizabeth Juma, Amina Salim, et al.
Page
of 6